Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes (the IMDIAB IV study)

European Journal of Endocrinology

Volumn 137, Issue 3, 1997, Pages 234-239

  Pozzilli, Paolo ^a,b   Visalli, Natalia ^a   Cavallo, Maria Gisella ^a   Signore, Alberto ^a   Baroni, Marco G ^a   Buzzetti, Raffaella ^a   Fioriti, Elvira ^a   Mesturino, Chiara ^a   Fiori, Rossana ^a   Romiti, Alfredo ^a   Giovannini, Claudio ^a   Lucentini, Lucio ^a   Matteoli, Maria Cristina ^a   Crinò, Antonio ^a   Teodonio, Carlo ^a   Paci, Francesco ^a   Amoretti, Rita ^a   Pisano, Luigi ^a   Suraci, Maria Teresa ^a   Multari, Giuseppe ^a   Suppa, Mariantonietta ^a   Sulli, Nicoletta ^a   De Mattia, Giancarlo ^a   Faldetta, Maria Rita Cassone ^a   Boscherini, Brunetto ^a   Stoduto, Stefania ^a   Fonte, Maria Teresa ^a   Bitti, Maria Luisa Manca ^a   Marietti, Giovanni ^a   Ferrazzoli, Federica ^a   Greco, Aldo V ^a   Ghirlanda, Giovanni ^a   more..

^a IMDIAB Study Group   (Italy)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; C PEPTIDE; GLYCOSYLATED HEMOGLOBIN; INSULIN; NICOTINAMIDE;

ADOLESCENT; ADULT; ARTICLE; CELL FUNCTION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GLYCOSYLATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; C-PEPTIDE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; ISLETS OF LANGERHANS; LEUKOPENIA; NIACINAMIDE; PROSPECTIVE STUDIES; VITAMIN E;

EID: 0030833377     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1370234     Document Type: Article

References (34)

1. Atkinson MA & Maclaren NK. Mechanisms of disease: the pathogenesis of insulin-dependent diabetes mellitus. New England Journal of Medicine 1994 331 1428-1436.
2. Roep B, Kallan AA, Hazenbos WLW, Bruining GJ, Bailyes EM, Arden SD et al. T cell reactivity to 38 kD insulin secretory granule protein in patients with recent onset type I diabetes. Lancet 1991 337 1439-1441.
3. Kolb H & Kolb-Bacofen V. Nitric oxide: a pathogenic factor in autoimmunity. Immunology Today 1992 13 157-160.
4. Shah SC, Malone JI & Simpson NE. A randomized trial of intensive insulin therapy in newly diagnosed insulin dependent diabetes mellitus. New England Journal of Medicine 1989 320 550-554.
5. Pozzilli P & Maclaren NK. Immunotherapy at clinical diagnosis of insulin dependent diabetes. Trends in Endocrinology and Metabolism 1993 4 101-105.
6. Hill HR, Augustine ML, Rallison ML & Santos JL. Defective monocyte chemotactic responses in diabetes mellitus. Journal of Clinical Immunology 1993 3 70-77.
7. Boxer LA, Oliver SO, Speilberg JM, Alien JM & Shulman JD. Protection of granulocytes by Vit E in glutathione synthetase deficiency. New England Journal of Medicine 1979 301 901-905.
8. Watson RR & Petro TM. Cellular immune response, corticosteroid levels and resistance to Listeria monocytogenes and murine leukaemia in mice fed a high Vit E diet. Annals of the New York Academy of Sciences 1982 393 205-210.
9. Watson RR & Leonard TK. Selenium and vitamins A, E and C: nutrients with cancer prevention. Journal of the American Medical Association 1986 85 505-510.
10. Rimm EB, Stampfer MJ, Acherio E. Giovannici GA, Colditz WC & Willett WC. Vitamin E consumption and the risk of coronary heart disease in man. New England Journal of Medicine 1993 328 1450-1456.
11. Jialal I & Grundy SM. Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density Iipoproteins. Journal of Lipid Research 1992 33 899-906.
12. Rabinovitch A, Suarez WL, Thomas PD, Strynadka K & Simpson I. Cytotoxic effects of cytokines on rat islets: evidence for involvement of free radicals and lipid peroxidation. Diabetologia 1992 35 409-413.
13. Hayward AR, Shriber M & Sokol R. Vit E supplementation reduces the incidence of diabetes but not insulitis in NOD mice. Journal of Laboratory and Clinical Medicine 1992 119 503-507.
14. Beales PE, Williams AJK, Albertini MC & Pozzilli P. Vitamin E delays diabetes onset in the non-obese diabetic mouse. Hormone and Metabolism Research 1994 26 450-452.
15. Pozzilli P & Andreani D. The potential role of nicotinamide in the secondary prevention of IDDM. Diabetes Metabolism Reviews 1993 9 219-230.
16. Andersen HU, Jorgensen KH, Egeberg J, Mandrup-Poulsen T & Nerup J. Nicotinamide prevents interleukin-1 effects on accumulated insulin release and nitric oxide production in rat islets of Langerhans. Diabetes 1994 43 770-777.
17. Pozzilli P, Visalli N, Signore A, Baroni MG, Buzzetti R, Cavallo MG et al. Double blind trial of nicotinamide in recent onset insulin dependent diabetes mellitus. Diabetologia 1995 38 848-852.
18. Pozzilli P, Browne PD, Kolb H and the Nicotinamide Trialists. Meta-analysis of nicotinamide treatment in patients with recent onset insulin dependent diabetes. Diabetes Care 1996 19 1357-1363.
19. Rothman KJ & Michels KB. The continuing unethical use of placebo controls. New England Journal of Medicine 1994 331 394-398.
20. Kolb H, Bach JF, Eisenbarth GS, Harrison LC, Maclaren NK, Pozzilli P et al. Criteria for immune trials in type 1 diabetes. Lancet 1989 2 686.
21. Meydani M. Vitamin E. Lancet 1995 345 170-175.
22. Kowdley KV, Meydani SN, Cornwall SC, Grand RJ & Mason JB. Reversal of depressed T-lymphocyte function with repletion of vitamin E deficiency. Gastroenterology 1992 102 1-4.
23. Moutschen MP, Scheen AJ & Lefebvre PJ. Impaired immune responses in diabetes mellitus: analysis of the factors involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabete et Metabolisme 1992 8 187-201.
24. Pozzilli P & Leslie RDG. Infections and diabetes: mechanisms and prospects for prevention. Diabetic Medicine 1994 11 935-941.
25. Cetkovic-Cvrlje M, Sandler S & Eizirik DL. Nicotinamide and dexamethasone inhibit IL-1 induced nitric oxide production by RINm5F cells without decreasing mRNA expression for nitric oxide synthase. Endocrinology 1993 133 1739-1743.
26. Kallamann B, Burkart V. Kroncke KD, Kolb-Baclofen V & Kolb H. Toxicity of chemically generated nitric oxide towards pancreatic islet cell can be prevented by nicotinamide. Life Sciences 1992 51 671-678.
27. Radons J, Heller B, Burkle A, Hartman B, Rodriguez ML, Kronoke KD et al. Nitric oxide toxicity in islet cells involves poly (ADP-ribose) polymerase activation and concomitant NAD+depletion. Biochemical and Biophysical Research Communications 1994 199 1270-1277.
28. Yamada K, Miyajima E & Nonaka K. Inhibition of cytokineinduced MHC class II but not class I molecule expression on mouse islet cells by nicotinamide and 3-aminobenzamide. Diabetes 1990 39 1125-1130.
29. Yamada K, Nonaka K, Hanafusa T, Kentaro Y. Kyohei N & Tauri S.. Preventive and therapeutic effects of large-dose nicotinamide injections on diabetes associated with insulitis. Diabetes 1982 31 749-753.
30. Bowman MA, Leiter EH & Atkinson MA. Prevention of diabetes in the NOD mouse: implications for therapeutic intervention in human disease. Immunology Today 1994 15 115-120.
31. Elliott RB, Pilcher CC, Stewart A, Fergusson D & MacGregor MA. The use of nicotinamide in the prevention of type 1 diabetes. Immunosuppressive and anti-inflammatory drugs. Annals of the New York Academy of Sciences 1991 696 333-338.
32. Bhathena SJ, Berlin E, Judd JT, Kim YC, Law JS, Bhagavan HN et al. Effects of omega 3 fatty acids and vitamin E on hormones involved in carbohydrate and lipid metabolism in men. American Journal of Clinical Nutrition 1993 54 684-688.
33. Pozzilli P, Visalli N, Signore A, Baroni MG, Buzzetti R. Cavallo MG et al. Adjuvant therapy in recent onset Type 1 diabetes at diagnosis and insulin requirement after 2 years. Diabete et Metabolisme 1995 21 47-49.
34. Ceriello A, Giugliano D, Quatraro A, Donzella C, Dipalo G & Lefebvre PJ. Vitamin E reduction of protein glycosylation in diabetes: New prospect for prevention of diabetic complications? Diabetes Care 1991 14 68-72.